Particle.news
Download on the App Store

Novo Nordisk Cuts Cash Prices for Wegovy and Ozempic to $349, Launches $199 Starter Offer

The move advances the administration's discount plan by accelerating promised price cuts.

Overview

  • Effective Monday, most Wegovy doses and Ozempic now cost $349 per month for cash-paying patients, with Ozempic's 2 mg dose staying at $499.
  • New patients can pay $199 per month for the first two months at the two lowest doses of Wegovy or Ozempic under an introductory offer running through March 31, 2026.
  • Discounted access is available via Wegovy.com, Ozempic.com, NovoCare, and partners such as GoodRx, Costco, and WeightWatchers, with availability reported at more than 70,000 pharmacies.
  • GoodRx said it will offer a weight-loss telehealth service for Wegovy and Ozempic at $39 per month for early subscribers before rising to $119 after February 1, 2026.
  • The pricing changes follow deals with the Trump administration that set TrumpRx cash prices trending from roughly $350 toward $245, target a $245 net price for Medicare and Medicaid injectables, and list Eli Lilly's Zepbound at $299 to $449 for cash buyers beginning in January.